YOSEMITE
E827934
YOSEMITE is a phase III clinical trial evaluating the efficacy and safety of faricimab in patients with diabetic macular edema.
Statements (26)
| Predicate | Object |
|---|---|
| instanceOf |
clinical trial
ⓘ
phase III clinical trial ⓘ |
| controlComparator | aflibercept ⓘ |
| drugClassEvaluated | bispecific antibody ⓘ |
| endpointCategory |
anatomical retinal outcomes
ⓘ
safety and tolerability ⓘ visual acuity outcomes ⓘ |
| evaluatesCondition | diabetic macular edema ⓘ |
| evaluatesDrug | faricimab NERFINISHED ⓘ |
| evaluatesIndication | diabetic macular edema ⓘ |
| indicationCategory | diabetic eye disease ⓘ |
| population | adult patients with diabetic macular edema ⓘ |
| primaryObjective | evaluate efficacy of faricimab in diabetic macular edema ⓘ |
| routeOfAdministration | intravitreal injection ⓘ |
| secondaryObjective | evaluate safety of faricimab in diabetic macular edema ⓘ |
| sponsor |
Genentech
NERFINISHED
ⓘ
Roche NERFINISHED ⓘ |
| studyDesign |
active-controlled
ⓘ
double-masked ⓘ multicenter ⓘ randomized ⓘ |
| studyType | interventional ⓘ |
| targetsPathway |
Angiopoietin-2
NERFINISHED
ⓘ
VEGF-A NERFINISHED ⓘ |
| therapeuticArea | ophthalmology ⓘ |
| trialPhase | Phase III ⓘ |
Referenced by (1)
Full triples — surface form annotated when it differs from this entity's canonical label.